News
SNPHY
10.53
NaN%
--
Santen Pharmaceutical Co., Ltd. GAAP EPS of ¥66.05, revenue of ¥210.76B
Seeking Alpha · 02/05 15:33
Santen Pharmaceutical Co., - Depositary Receipt (SNPHY) Price Target Decreased by 10.74% to 13.32
NASDAQ · 11/09/2025 01:01
Santen Pharmaceutical reports Q2 results
Seeking Alpha · 11/06/2025 17:30
Santen Pharmaceutical’s Promising Phase III Glaucoma Study: A Market Game-Changer?
TipRanks · 10/27/2025 17:24
Santen Pharmaceutical’s Phase III Study on STN1013800: A Potential Game-Changer for Acquired Blepharoptosis Treatment in China
TipRanks · 10/27/2025 16:42
Santen Pharmaceutical Co (SNPHF) Receives a Buy from Goldman Sachs
Barchart · 10/11/2025 06:26
Weekly Report: what happened at SNPHY last week (0908-0912)?
Weekly Report · 09/15/2025 10:17
Weekly Report: what happened at SNPHY last week (0901-0905)?
Weekly Report · 09/08/2025 10:19
Weekly Report: what happened at SNPHY last week (0825-0829)?
Weekly Report · 09/01/2025 10:16
Weekly Report: what happened at SNPHY last week (0818-0822)?
Weekly Report · 08/25/2025 10:22
Citi Sticks to Its Buy Rating for Santen Pharmaceutical Co (SNPHF)
TipRanks · 08/22/2025 11:25
Weekly Report: what happened at SNPHY last week (0811-0815)?
Weekly Report · 08/18/2025 10:17
Weekly Report: what happened at SNPHY last week (0804-0808)?
Weekly Report · 08/11/2025 10:21
Santen Pharmaceutical Co (SNPHF) was downgraded to a Hold Rating at Jefferies
TipRanks · 08/10/2025 12:15
Weekly Report: what happened at SNPHY last week (0728-0801)?
Weekly Report · 08/04/2025 10:23
Weekly Report: what happened at SNPHY last week (0721-0725)?
Weekly Report · 07/28/2025 10:24
Weekly Report: what happened at SNPHY last week (0714-0718)?
Weekly Report · 07/21/2025 10:17
Weekly Report: what happened at SNPHY last week (0707-0711)?
Weekly Report · 07/14/2025 10:23
Weekly Report: what happened at SNPHY last week (0630-0704)?
Weekly Report · 07/07/2025 10:18
Weekly Report: what happened at SNPHY last week (0623-0627)?
Weekly Report · 06/30/2025 10:22
More
Webull provides a variety of real-time SNPHY stock news. You can receive the latest news about Santen Pharmaceutical Co Ltd through multiple platforms. This information may help you make smarter investment decisions.
About SNPHY
Santen Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, and sale of pharmaceuticals. The Company engages in global research and development, manufacture, sale, and marketing of pharmaceuticals in the ophthalmology field. The Company engages in prescription pharmaceuticals, over-the-counter pharmaceuticals, medical devices, and other businesses. The Company operates in Japan, Asia, Europe, the Middle East, and Africa (EMEA), China, and other regions.